Literature DB >> 20514599

[Spondylodiscitis - an interdisciplinary challenge].

K Zarghooni1, M Röllinghoff, J Siewe, G Fätkenheuer, H Seifert, P Eysel, R Sobottke.   

Abstract

HISTORY AND ADMISSION
FINDINGS: A 21-year-old man presented with severe lumbar back pain and progressive paraparesis with clinical signs of spondylitis. Laboratory findings revealed elevated infectious parameters. Because of a positive Mantoux-Test he had been treated with quadruple tuberculostatic drugs for eight weeks without prior identification of the causative pathogen. INVESTIGATIONS: Magnetic resonance imaging of the spine revealed a multisegmental spondylitis of the lumbar vertebrae (L3 - L5) with epidural empyema. Computed tomography (CT) of the abdomen confirmed large bilateral abscesses in the psoas muscles. TREATMENT AND COURSE: The findings supported the diagnosis of spondylitis. The antibiotic regimen was continued. CT-guided drainage was placed in both psoas muscles. Laminectoma of L3 - 5 and dorsal spondylodesis of L2 - S1 were performed immediately. Mycobacterium tuberculosis was cultured from the intraoperative biopsies and treated according to the drug sensitivity test. After further surgical debridment and corporectomy of L4 and L5 the infection was successfully treated. Ten weeks after admission the patient was transferred to a neurologic rehabilitation unit for mobilization.
CONCLUSION: Spondylodiscitis treatment is complex and requires a multidisciplinary approach. Georg Thieme Verlag KG Stuttgart, New York.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20514599     DOI: 10.1055/s-0030-1255128

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  2 in total

Review 1.  Treatment of spondylodiscitis.

Authors:  Kourosh Zarghooni; Marc Röllinghoff; Rolf Sobottke; Peer Eysel
Journal:  Int Orthop       Date:  2011-12-06       Impact factor: 3.075

2.  [Standards of microbiological diagnostics of spondylodiscitis].

Authors:  B Lehner; M Akbar; C Rehnitz; G W Omlor; U Dapunt; I Burckhardt
Journal:  Orthopade       Date:  2012-09       Impact factor: 1.087

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.